Determination of Myloid Antigen Expression on Childhood Acute Lymphoblastic Leukaemia Cells: Discrepancies Using Different Monoclonal Antibody Clones
暂无分享,去创建一个
G. Leverger | R. Favier | L. Douay | H. Firat | J. Landman-Parker | Y. Cayre | M. Adam
[1] J. Downing,et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] R. Consolini,et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. , 1998, Blood.
[3] F. Sigaux,et al. The majority of myeloid‐antigen‐positive (My+) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts , 1997, British journal of haematology.
[4] Maria Grazia Valsecchi,et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials , 1997 .
[5] H. Sather,et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1997, Blood.
[6] A. Look,et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. , 1997, Blood.
[7] F. Sigaux,et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. , 1994, Blood.
[8] G. Martinelli,et al. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications , 1994, British journal of haematology.
[9] A. Baruchel,et al. Use of immunophenotype as part of the prognostic stratification for childhood ALL in the FRALLE 93 protocol. , 1994, Leukemia & lymphoma.
[10] R. Foà,et al. Co‐expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance , 1991, British journal of haematology.
[11] E. Thiel,et al. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. , 1991, Leukemia.
[12] F. Davey,et al. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia , 1991, Cancer.
[13] K. Weinberg,et al. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. , 1991, The New England journal of medicine.
[14] D. Treille,et al. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. , 1990, Leukemia.
[15] F. Behm,et al. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. , 1990, Blood.
[16] E. Montserrat,et al. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia , 1990, British journal of haematology.
[17] F. Behm,et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. , 1990, Blood.
[18] J. Reuben,et al. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics. , 1989, Leukemia.
[19] I Royston,et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. , 1987, The New England journal of medicine.
[20] C. Pui,et al. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. , 1985, Blood.
[21] H. Gralnick,et al. The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations , 1981, British journal of haematology.